SurModics Reports Third Quarter Fiscal 2016 Results
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2016 third quarter, ended June 30, 2016.
“Surmodics continued to advance all key strategic growth priorities while delivering against our fiscal 2016 financial commitments,” said Gary Maharaj, president and chief executive officer.
“Surmodics continued to advance all key strategic growth priorities while delivering against our fiscal 2016 financial commitments,” said Gary Maharaj, president and chief executive officer.